The largest database of trusted experimental protocols

4 protocols using fin56

1

Generation and Characterization of ATF3 Knockout Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HT1080 cells expressing ATF3 and empty vector were generated previously [26 (link)]. Retinal pigment epithelial (RPE) cells immortalized with hTERT were obtained from Dr. Todd Waldman [27 (link)]. To generate ATF3-knockout cells, a target sequence (5′-AAAATGATGCTTCAACACCC-3′) spanning the ATF3 start codon was inserted into pSpCas9(BB)-2A-puro, and used to transfect RPE and U2OS cells as described [28 (link)]. ATF3-knockout HCT116 cells were generated using rAAV-mediated homologous recombination as described previously [14 ]. These cells were cultured in media supplemented with 10% fetal bovine serum. We used DMEM for HT1080, RPE, DU145, and U2OS cells, RPMI 1640 for PC3 cells, and McCoy’s 5A for HCT116 cells. Erastin, RSL3, ferrostatin-1, BSO, Z-VAD-FMK, and FIN56 were purchased from Cayman Chemical. N-acetylcysteine (NAC) was purchased from Thermo Fisher Scientific. Other reagents were obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
2

Ferroptosis Inducers and Inhibitors Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
erastin (Bio-techne, 5449); SAS (MedchemExpress, HY-14655); RSL3 (Cayman, 19288); FIN56 (Cayman, 25180); FINO2 (MedchemExpress, HY-129457); PANKi (Cayman, 31002); BSO (Sigma, B2515); DEM (Sigma, D97703); etomoxir sodium salt (Selleckchem, S8244); lovastatin (Selleckchem, S2061); TOFA (Selleckchem, S6690); dorsomorphin (Selleckchem, S7306); alisertib (Selleckchem, S1133); verdinexor (Cayman, 26171); leptomycin B (Cayman, 10004976); tipifarnib (MedchemExpress, HY-10502); methotrexate (Selleckchem, S1210); pitstop2 (Sigma, SML1169); EML425 (Selleckchem, S2977); C646 (Selleckchem, S7152); brequinar (Selleckchem, S3565); elamipretide (Selleckchem, S9803)
+ Open protocol
+ Expand
3

Ferroptosis Regulators Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lip-1 (Selleckchem, cat. no. S7699), doxycycline (Dox; Sigma, cat. no. D9891), RSL3 (Cayman, cat. no. 19288), BSO (Sigma, cat. no. B2515), iFSP1 (ChemDiv, cat. no. 8009-2626), icFSP1 (ChemDiv, cat. no. L892-0224 or custom synthesis by Intonation Research Laboratories), erastin (Merck, cat. no. 329600), ML210 (Cayman, cat. no. Cay23282-1), FIN56 (Cayman, cat. no. Cay25180-5), FINO2 (Cayman, cat. no. Cay25096-1), deferoxamine mesylate salt (DFO; Sigma, cat. no. 138-14-7), ferrostatin-1 (Fer-1; Sigma, cat. no. SML0583), zVAD-FMK (zVAD; Enzo Life Sciences, cat. no. ALX-260-02), necrostatin-1s (Nec-1s; Enzo Life Sciences, cat. no. BV-2263-5), MCC950 (Sigma, cat. no. 5381200001), olaparib (Selleckchem, cat. no. S1060), staurosporine (STS; Cayman, cat. no. 81590), recombinant human tumour necrosis factor (TNF; R&D Systems, cat. no. NBP2-35076), Smac mimic (BV-6; Selleckchem, cat. no. S7597), nigericin (Thermo Fisher, cat. no. N1495), IMP-1088 (Cayman, cat. no. Cay25366-1) and lipopolysaccharide (LPS; Sigma, cat. no. L2880) were used in this study.
+ Open protocol
+ Expand
4

Ferroptosis Induction and Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines used in this study were purchased from the American Type Culture Collection and were free of mycoplasma contamination (tested by the vendor). No cell line used in this study has been found in the International Cell Line Authentication Committee database of commonly misidentified cell lines, based on short tandem-repeat profiling performed by the vendor. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% (vol/vol) fetal bovine serum (FBS) and 1% (vol/vol) penicillin/streptomycin in a humidified atmosphere of 5% CO2 at 37 °C as described previously (38 (link), 39 (link)). All cell lines were seeded into a 12-well plate for cell death and lipid peroxidation measurements. Cells were treated with ferroptosis inducers, including RSL3 (Selleck Chemicals), ML210 (Cayman Chemical), ML162 (Cayman Chemical), and FIN56 (Cayman Chemical); ferroptosis inhibitors, including liproxstatin-1 (Cayman Chemical) and ferrostatin-1 (Sigma-Aldrich); deferoxamine (Sigma-Aldrich); glycerol (Sigma-Aldrich); sn-G3P (Cayman Chemical); the GPD2 inhibitor iGP-1 - Calbiochem (Sigma-Aldrich); and antioxidants, including 2,2,6,6-tetramethylpiperidinyl-1-oxy (TEMPO; Sigma-Aldrich), mitochondria-targeted TEMPO (MitoTEMPO; Sigma-Aldrich), MitoQ (Cayman Chemical), and MitoQH2 (Cayman Chemical).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!